NRX Pharmaceuticals, Inc. Common Unit, Issuance Value
NRX Pharmaceuticals, Inc. (NRXP) had Common Unit, Issuance Value of $10.00 million as of 2020-02-12, per its 10-Q/A filed 2022-08-12.
Discontinued › Balance Sheet › Equity
us-gaap:CommonUnitIssuanceValue · last filed 2022-08-12
- 2020-02-12: Common Unit, Issuance Value $10.00M.
| Period end | Common Unit, Issuance Value |
|---|---|
| 2020-02-12 | $10.00M 10-Q/A · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |